Hepatobiliary Surgery: Indications, Evaluation and Outcomes

  • Jay A. Graham
  • Milan Kinkhabwala


Complex surgical intervention for liver disease is a relatively new addition in medical practice and reliable standards of success were only achieved only in the past three decades. Earlier attempts at surgical resection were commonly associated with high rates of morbidity and mortality. Advancements in our understanding of liver physiology and anatomy, technological advancements, dissemination of standardized surgical techniques, and advances in perioperative anesthesia management have all contributed to substantial improvements in the success of major hepatic surgery.

The aim of this chapter is to review the surgical techniques and indications for major hepatic surgery.

Liver Anatomy

It is impossible to begin a discussion of hepatobiliary surgery without referencing Claude Couinaud’s (1922–2008) pioneering work [1]. By wax casting the vasculature and biliary tree of cadaveric livers in his laboratory in Neuilly-sur-Seine, Couinaud ushered in a new understanding of...


Hepatic resection Surgical technique Pringle maneuver Laparoscopic liver resection Liver abscesses Liver tumor 


  1. 1.
    Couinaud CLF. Etudes anatomiques et chirurgicales. Paris: Masson; 1957.Google Scholar
  2. 2.
    Aloia TA, Fahy BN, Fischer CP, et al. Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB (Oxford). 2009;11(6):510–5.CrossRefGoogle Scholar
  3. 3.
    Mayo SC, Pawlik TM. Current management of colorectal hepatic metastasis. Expert Rev Gastroenterol Hepatol. 2009;3(2):131–44.CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Are C, Gonen M, Zazzali K, et al. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg. 2007;246(2):295–300.CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Liddo G, Buc E, Nagarajan G, Hidaka M, Dokmak S, Belghiti J. The liver hanging manoeuvre. HPB (Oxford). 2009;11(4):296–305.CrossRefGoogle Scholar
  6. 6.
    Yoshimoto M, Endo K, Hanaki T, et al. Effectiveness of the LigaSure small jaw vessel-sealing system in hepatic resection. Yonago Acta Med. 2014;57(2):93–8.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Jarnagin W, Chapman WC, Curley S, et al. Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010;12(5):302–10.CrossRefGoogle Scholar
  8. 8.
    Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: current status. World J Radiol. 2010;2(11):417–24.CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Gagner M, Pomp A, Heniford BT, Pharand D, Lacroix A. Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Ann Surg. 1997;226(3):238–46. discussion 246–7CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Gagner M, Rogula T, Selzer D. Laparoscopic liver resection: benefits and controversies. Surg Clin North Am. 2004;84(2):451–62.CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Dagher I, O’Rourke N, Geller DA, et al. Laparoscopic major hepatectomy: an evolution in standard of care. Ann Surg. 2009;250(5):856–60.CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-2,804 patients. Ann Surg. 2009;250(5):831–41.CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Kazaryan AM, Marangos IP, Rosok BI, et al. Laparoscopic resection of colorectal liver metastases: surgical and long-term oncologic outcome. Ann Surg. 2010;252(6):1005–12.CrossRefPubMedCentralGoogle Scholar
  14. 14.
    Eiriksson K, Fors D, Rubertsson S, Arvidsson D. High intra-abdominal pressure during experimental laparoscopic liver resection reduces bleeding but increases the risk of gas embolism. Br J Surg. 2011;98(6):845–52.CrossRefPubMedCentralGoogle Scholar
  15. 15.
    Heimbach J, Kulik LM, Finn R, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67:358–80.CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Soler L, Nicolau S, Pessaux P, Mutter D, Marescaux J. Real-time 3D image reconstruction guidance in liver resection surgery. Hepatobiliary Surg Nutr. 2014;3(2):73–81.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Bidwell LA. Hepatic abscess following acute appendicitis. Br Med J. 1910;2(2591):507–8.CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Choi D, Lim HK, Kim MJ, et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. Am J Roentgenol. 2005;184(6):1860–7.CrossRefGoogle Scholar
  19. 19.
    Hammer MM, Mellnick VM, Raptis CA, Schmidt R, Fowler KJ. Peripheral restricted diffusion: a common appearance of hepatic abscesses. J Comput Assist Tomogr. 2015;39(6):890–5.CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Seeto RK, Rockey DC. Pyogenic liver abscess. Changes in etiology, management, and outcome. Medicine (Baltimore). 1996;75(2):99–113.CrossRefGoogle Scholar
  21. 21.
    Pearce NW, Knight R, Irving H, et al. Non-operative management of pyogenic liver abscess. HPB (Oxford). 2003;5(2):91–5.CrossRefGoogle Scholar
  22. 22.
    Agrawal BV, Somani PN, Khanna MN, Srivastava PK, Jha BN, Verma SP. Amebic pericardial effusion: a rare complication of amebic liver abscess. Am Surg. 1975;41(6):373–7.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Mihmanli M, Idiz UO, Kaya C, et al. Current status of diagnosis and treatment of hepatic echinococcosis. World J Hepatol. 2016;8(28):1169–81.CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Sayek I, Onat D. Diagnosis and treatment of uncomplicated hydatid cyst of the liver. World J Surg. 2001;25(1):21–7.CrossRefPubMedCentralGoogle Scholar
  25. 25.
    Czermak BV, Akhan O, Hiemetzberger R, et al. Echinococcosis of the liver. Abdom Imaging. 2008;33(2):133–43.CrossRefPubMedCentralGoogle Scholar
  26. 26.
    Berney T, Mentha G, Morel P. Total vascular exclusion of the liver for the resection of lesions in contact with the vena cava or the hepatic veins. Br J Surg. 1998;85(4):485–8.CrossRefPubMedCentralGoogle Scholar
  27. 27.
    Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48(1):163–70.CrossRefPubMedCentralGoogle Scholar
  28. 28.
    Deneve JL, Pawlik TM, Cunningham S, et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol. 2009;16(3):640–8.CrossRefPubMedCentralGoogle Scholar
  29. 29.
    Weimann A, Mossinger M, Fronhoff K, Nadalin S, Raab R. Pregnancy in women with observed focal nodular hyperplasia of the liver. Lancet. 1998;351(9111):1251–2.CrossRefPubMedCentralGoogle Scholar
  30. 30.
    Noels JE, van Aalten SM, van der Windt DJ, et al. Management of hepatocellular adenoma during pregnancy. J Hepatol. 2011;54(3):553–8.CrossRefPubMedCentralGoogle Scholar
  31. 31.
    Huurman VA, Schaapherder AF. Management of ruptured hepatocellular adenoma. Dig Surg. 2010;27(1):56–60.CrossRefPubMedCentralGoogle Scholar
  32. 32.
    Stoot JH, van der Linden E, Terpstra OT, Schaapherder AF. Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization. Br J Surg. 2007;94(10):1249–53.CrossRefPubMedCentralGoogle Scholar
  33. 33.
    Kelly ME, Spolverato G, Le GN, et al. Synchronous colorectal liver metastasis: a network meta-analysis review comparing classical, combined, and liver-first surgical strategies. J Surg Oncol. 2015;111(3):341–51.CrossRefPubMedCentralGoogle Scholar
  34. 34.
    Gedaly R, Daily MF, Davenport D, et al. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg. 2011;146(8):953–8.CrossRefGoogle Scholar
  35. 35.
    Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis. 2001;21(1):105–13.CrossRefGoogle Scholar
  36. 36.
    Khanna R, Sarin SK. Non-cirrhotic portal hypertension—diagnosis and management. J Hepatol. 2014;60(2):421–41.CrossRefGoogle Scholar
  37. 37.
    Alvarez FA, Ardiles V, de Santibanes M, Pekolj J, de Santibanes E. Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. Ann Surg. 2015;261(4):723–32.CrossRefGoogle Scholar
  38. 38.
    Wulf J, Guckenberger M, Haedinger U, et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol. 2006;45(7):838–47.CrossRefGoogle Scholar
  39. 39.
    Forner A, Gilabert M, Bruix J, Raoul JL. Treatment of intermediate-stage hepatocellular carcinoma. Nat Rev Clin Oncol. 2014;11(9):525–35.CrossRefGoogle Scholar
  40. 40.
    Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–90.CrossRefPubMedCentralGoogle Scholar
  41. 41.
    Day RW, Brudvik KW, Vauthey JN, et al. Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery. Surgery. 2016;159(3):793–801.CrossRefPubMedCentralGoogle Scholar
  42. 42.
    Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford). 2014;16(5):459–68.CrossRefGoogle Scholar
  43. 43.
    Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–24.CrossRefPubMedCentralGoogle Scholar
  44. 44.
    Okabe H, Beppu T, Ishiko T, et al. Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease-free survival. J Surg Oncol. 2011;104(6):641–6.CrossRefPubMedCentralGoogle Scholar
  45. 45.
    Sotiropoulos GC, Druhe N, Sgourakis G, et al. Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? Dig Dis Sci. 2009;54(10):2264–73.CrossRefPubMedCentralGoogle Scholar
  46. 46.
    Wagener G. Assessment of hepatic function, operative candidacy, and medical management after liver resection in the patient with underlying liver disease. Semin Liver Dis. 2013;33(3):204–12.CrossRefGoogle Scholar
  47. 47.
    Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC. Predictive indices of morbidity and mortality after liver resection. Ann Surg. 2006;243(3):373–9.CrossRefPubMedCentralGoogle Scholar
  48. 48.
    Simons JP, Ng SC, Hill JS, Shah SA, Zhou Z, Tseng JF. In-hospital mortality from liver resection for hepatocellular carcinoma: a simple risk score. Cancer. 2010;116(7):1733–8.CrossRefPubMedCentralGoogle Scholar
  49. 49.
    Cucchetti A, Ercolani G, Vivarelli M, et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 2006;12(6):966–71.CrossRefPubMedCentralGoogle Scholar
  50. 50.
    Hsu KY, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg. 2009;33(11):2412–9.CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of SurgeryAlbert Einstein College of MedicineBronxUSA

Personalised recommendations